{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T01:28:06Z","timestamp":1776130086775,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T00:00:00Z","timestamp":1533772800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bundesgesundheitsbl"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s00103-018-2798-8","type":"journal-article","created":{"date-parts":[[2018,8,9]],"date-time":"2018-08-09T11:09:35Z","timestamp":1533812975000},"page":"1129-1138","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Arzneimitteltherapiesicherheit in der Schwangerschaft \u2013 eine besondere Herausforderung","Drug safety in pregnancy\u2014a\u00a0particular challenge"],"prefix":"10.1007","volume":"61","author":[{"given":"Christof","family":"Schaefer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2018,8,9]]},"reference":[{"key":"2798_CR1","unstructured":"European Medicines Agency, CHMP (2008) Guideline on risk assessment of medicinal products on human reproduction and lactation: from data to labelling, EMEA\/CHMP\/203927\/2005. \n                    https:\/\/www.google.com\/search?q=Guideline+on+risk+assessment+of+medicinal+products+on+human+reproduction+and+lactation%3A+from+data+to+labelling&ie=utf-8&oe=utf-8&client=firefox-b-ab\n                    \n                  . Zugegriffen: 02.08.2018"},{"key":"2798_CR2","volume-title":"Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling","author":"Food and Drug Administration","year":"2014","unstructured":"Food and Drug Administration (2014) Content and format of labeling for human prescription drug and biological products; requirements for pregnancy and lactation labeling. \n                    http:\/\/federalregister.gov\/a\/2014-28241\n                    \n                   (Erstellt: 9. Okt. 2014). Zugegriffen: 02.08.2018"},{"key":"2798_CR3","volume-title":"Drugs during pregnancy and lactation","author":"C Schaefer","year":"2015","unstructured":"Schaefer C, Peters P, Miller RKM (2015) Drugs during pregnancy and lactation, 3.\u00a0Aufl. Elsevier, Academic Press, New York","edition":"3"},{"key":"2798_CR4","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1001\/jama.2017.21896","volume":"319","author":"PA May","year":"2018","unstructured":"May PA, Chambers CD, Kalberg WO et\u00a0al (2018) Prevalence of fetal alcohol spectrum disorders in 4 US communities. JAMA 319:474\u2013482","journal-title":"JAMA"},{"key":"2798_CR5","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1056\/NEJMsa1506575","volume":"374","author":"LB Finer","year":"2016","unstructured":"Finer LB, Zolna MR (2016) Declines in unintended pregnancy in the United States, 2008\u20132011. N\u00a0Eng J Med 374:843\u2013852","journal-title":"N Eng J Med"},{"key":"2798_CR6","unstructured":"Statistisches Bundesamt Wiesbaden; \n                    statistik-portal.de\/Statistik-Portal\/de_jb01_jahrtab1.asp\n                    \n                  . Zugegriffen: 02.08.2018"},{"key":"2798_CR7","volume-title":"European surveillance of congenital anomalies: malformation coding guides","author":"EUROCAT","year":"2018","unstructured":"EUROCAT (2018) European surveillance of congenital anomalies: malformation coding guides. \n                    http:\/\/www.eurocat-network.eu\/aboutus\/datacollection\/guidelinesforregistration\/malformationcodingguides\n                    \n                  . Zugegriffen: 18.02.2018"},{"key":"2798_CR8","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.reprotox.2016.11.019","volume":"67","author":"E Beck","year":"2017","unstructured":"Beck E, Lechner A, Schaefer C (2017) Who seeks teratology information service\u2019s advice? Assessing the risk of selection bias in observational cohort studies on drug risks in pregnancy. Reprod Toxicol 67:79\u201387","journal-title":"Reprod Toxicol"},{"key":"2798_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.reprotox.2008.05.064","volume":"26","author":"C Schaefer","year":"2008","unstructured":"Schaefer C, Ornoy A, Clementi M, Meister R, Weber-Schoendorfer C (2008) Using observational cohort data for studying drug effects on pregnancy outcome\u2014methodological considerations. Reprod Toxicol 26:36\u201341","journal-title":"Reprod Toxicol"},{"key":"2798_CR10","doi-asserted-by":"publisher","first-page":"862","DOI":"10.4065\/74.9.862","volume":"74","author":"I Meissner","year":"1999","unstructured":"Meissner I, Whisnant JP, Khandheria BK et\u00a0al (1999) Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a\u00a0Community. Mayo Clin Proc 74:862\u2013869","journal-title":"Mayo Clin Proc"},{"key":"2798_CR11","unstructured":"Innovative Medicines Initiative (2017) IMI2, 13th call for proposals. \n                    http:\/\/ec.europa.eu\/research\/participants\/data\/ref\/h2020\/other\/call_fiches\/jtis\/h2020-call-fiche17-13-imi2-ju_en.pdf\n                    \n                  . Zugegriffen: 02.08.2018"},{"key":"2798_CR12","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1001\/jamapediatrics.2013.4914","volume":"168","author":"Z Liew","year":"2014","unstructured":"Liew Z, Ritz B, Rebordosa C, Lee PC, Olsen J (2014) Acetaminophen use during pregnancy, behavioral problems, and hyperkinetic disorders. JAMA Pediatr 168:313\u2013320","journal-title":"JAMA Pediatr."},{"key":"2798_CR13","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1093\/humrep\/der474","volume":"27","author":"CA Snijder","year":"2012","unstructured":"Snijder CA, Kortenkamp A, Steegers EA et\u00a0al (2012) Intrauterine exposure to mild analgesics during pregnancy and the occurrence of cryptorchidism and hypospadia in the offspring: the Generation R Study. Hum Reprod 27:1191\u20131201","journal-title":"Hum Reprod"},{"key":"2798_CR14","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.prrv.2012.04.004","volume":"14","author":"AJ Henderson","year":"2013","unstructured":"Henderson AJ, Shaheen SO (2013) Acetaminophen and asthma. Paediatr Respir Rev 14:9\u201315","journal-title":"Paediatr. Respir. Rev."},{"key":"2798_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.eurpsy.2017.10.007","author":"C-G Bornehag","year":"2017","unstructured":"Bornehag C\u2011G, Reichenberg A, Unenge Hallerback M et al (2017) Prenatal exposure to acetaminophen and children\u2019s language development at 30\u00a0months. Eur Psychiatry. \n                    https:\/\/doi.org\/10.1016\/j.eurpsy.2017.10.007","journal-title":"Eur Psychiatry"},{"key":"2798_CR16","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1111\/j.1365-2125.2012.04388.x","volume":"75","author":"M Oppermann","year":"2013","unstructured":"Oppermann M, Padberg S, Kayser A, Weber-Schoendorfer C, Schaefer C (2013) Angiotensin-II receptor 1 antagonist fetopathy\u2014risk assessment, critical time period and vena cava thrombosis as a\u00a0possible new feature. Br J Clin Pharmacol 75:822\u2013830","journal-title":"Br. J. Clin. Pharmacol."},{"key":"2798_CR17","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s00404-009-1112-2","volume":"281","author":"C Schaefer","year":"2010","unstructured":"Schaefer C, Meister R, Weber-Schoendorfer C (2010) Isotretinoin exposure and pregnancy outcome\u2014an observational study of the Berlin institute for clinical teratology and drug risk assessment during pregnancy. Arch Gynecol Obstet 281:221\u2013227","journal-title":"Arch Gynecol Obstet"},{"key":"2798_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1212\/WNL.0000000000003157","volume":"87","author":"RL Bromley","year":"2016","unstructured":"Bromley RL, Calderbank R, Cheyne CP et al (2016) Cognition in school-age children exposed to levetiracetam, topiramate, or sodium valproate. Neurology 87:1\u201311","journal-title":"Neurology"},{"key":"2798_CR19","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1111\/epi.13007","volume":"56","author":"AG Wood","year":"2015","unstructured":"Wood AG, Nadebaum C, Anderson V et\u00a0al (2015) Prospective assessment of autism traits in children exposed to antiepileptic drugs during pregnancy. Epilepsia 56:1047\u20131055","journal-title":"Epilepsia"},{"key":"2798_CR20","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1212\/WNL.0000000000001772","volume":"85","author":"T Tomson","year":"2015","unstructured":"Tomson T, Battino D, Bonizzoni E et al (2015) Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study. Neurology 85:866\u2013872","journal-title":"Neurology"},{"key":"2798_CR21","volume-title":"Informationsbrief zur Einf\u00fchrung einer Patientenkarte f\u00fcr Arzneimittel, die Valproat und verwandte Substanzen enthalten","author":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte","year":"2018","unstructured":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte (2018) Informationsbrief zur Einf\u00fchrung einer Patientenkarte f\u00fcr Arzneimittel, die Valproat und verwandte Substanzen enthalten. \n                    http:\/\/www.bfarm.de\/SharedDocs\/Downloads\/DE\/Arzneimittel\/Pharmakovigilanz\/Risikoinformationen\/RI_rhb\/2017\/info-valproat-und-verwandte-substanzen.pdf?__blob=publicationFile&v=3\n                    \n                  . Zugegriffen: 01.02.2018"}],"container-title":["Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00103-018-2798-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-018-2798-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00103-018-2798-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T23:11:55Z","timestamp":1565305915000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00103-018-2798-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,8,9]]},"references-count":21,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["2798"],"URL":"https:\/\/doi.org\/10.1007\/s00103-018-2798-8","relation":{},"ISSN":["1436-9990","1437-1588"],"issn-type":[{"value":"1436-9990","type":"print"},{"value":"1437-1588","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,8,9]]},"assertion":[{"value":"9 August 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"C.\u00a0Schaefer gibt an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Dieser Beitrag beinhaltet keine von den Autoren durchgef\u00fchrten Studien an Menschen oder Tieren.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics"}}]}}